[1]韩 岳,左积文,陈丽丽,等.蛛网膜下腔出血患者不同神经功能恢复结局之间microRNAs 表达差异的meta 分析[J].现代检验医学杂志,2023,38(04):131-138.[doi:10.3969/j.issn.1671-7414.2023.04.024]
 HAN Yue,ZUO Jiwen,CHEN Lili,et al.Meta-analysis of Differential microRNA Expression between Different Neurological Recovery Outcomes in Patients with Subarachnoid Hemorrhage[J].Journal of Modern Laboratory Medicine,2023,38(04):131-138.[doi:10.3969/j.issn.1671-7414.2023.04.024]
点击复制

蛛网膜下腔出血患者不同神经功能恢复结局之间microRNAs 表达差异的meta 分析()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年04期
页码:
131-138
栏目:
论著
出版日期:
2023-07-15

文章信息/Info

Title:
Meta-analysis of Differential microRNA Expression between Different Neurological Recovery Outcomes in Patients with Subarachnoid Hemorrhage
文章编号:
1671-7414(2023)04-131-08
作者:
韩 岳1左积文1陈丽丽1王 静2
(1. 正定县人民医院外三科,石家庄 050800;2. 石家庄市第四医院产二科,石家庄 050011)
Author(s):
HAN Yue1 ZUO Jiwen1 CHEN Lili1 WANG Jing2
(1. the Third Department of Surgery,Zhengdingxian People’s Hospital, Shijiazhuang 050800, China;2. the Second Department of Obstetrics, the Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China)
关键词:
蛛网膜下腔出血微小核糖核酸神经功能meta 分析
分类号:
R743.35;R446
DOI:
10.3969/j.issn.1671-7414.2023.04.024
文献标志码:
A
摘要:
目的 评价蛛网膜下腔出血(subarachnoid hemorrhage,SAH)患者不同神经功能恢复结局之间的微小核糖核酸(micro-ribonucleic acid,microRNA)表达差异,根据microRNA 的表达差异探讨影响神经功能恢复的潜在机制。方法 计算机检索英文数据库PubMed,EmBase,Cochrane library,以及中文数据库中国知网(China national knowledgeinfrastructure,CNKI)、万方数据知识服务平台、重庆维普中文科技期刊数据库(China Science and TechnologyJournal Database,CSTJ)、中国生物医学文献服务系统,并检索了基因表达数据库包括高通量基因表达数据库(GeneExpression Omnibus,GEO)以及芯片表达谱数据库(Array Express)。搜集SAH 患者中关于microRNA 表达水平与不同神经功能恢复结局相关的病例对照研究。检索时间为建库至2022 年8 月。采用均数差值(mean difference,MD)及其95% 置信区间(confidence interval,CI)对microRNA 表达结果进行合并。对差异表达microRNA 的靶基因进行富集分析。结果 最终纳入发表于2017 ~ 2022 年的6 项研究。纳入研究均采用改良Rankin 量表(modified Rankin Scale,mRS)对神经功能恢复结局进行评估。Meta 分析结果认为,miR-152-3p [MD=-0.31,95%CI(-0.50,-0.13),矫正后P =0.006],miR-221-3p [MD=-0.26,95%CI(-0.40,-0.11),矫正后P=0.005],miR-34a-5p [MD=-0.28,95%CI(-0.46,-0.11),矫正后P= 0.009] 在神经功能恢复良好患者的脑脊液中表达水平低于神经功能恢复不良患者,差异具有统计学意义。而miR-210-3p [MD=0.23,95%CI(0.10,0.37),矫正后P = 0.006] 和miR-193b-3p [MD=0.16,95%CI(0.12,0.20),矫正后P= 0.002] 在神经功能恢复良好患者的脑脊液或外周血中表达水平高于神经功能恢复不良患者,差异具有统计学意义。靶基因富集分析显示PI3K-AKT 信号通路与SAH 患者神经功能恢复结局相关。结论 SAH 患者不同神经功能恢复结局之间microRNA 表达差异具有统计学意义,microRNA 有望成为判定神经功能恢复结局的生物标志物。靶基因富集分析证实了PI3K-AKT 信号通路在SAH 患者神经功能恢复中的关键作用。
Abstract:
Objective To evaluate differential micro-ribonucleic acid (microRNA) expression between different neurological function recovery outcomes in patients with subarachnoid hemorrhage (SAH) and to explore the potential mechanisms affecting neurological function recovery according to the differential microRNA expression. Methods Literature databases including PubMed,EmBase,Cochrane library, China national knowledge infrastructure (CNKI), Wanfang data knowledge service platform, China Science and Technology Journal Database (CSTJ), SinoMed, and the gene expression databases, including Gene Expression Omnibus (GEO) and Arrary Express, were searched from inception to August 2022. Study reported the microRNA expression in SAH patients with different neurological outcome were included. The microRNA expression results were pooled using mean difference (MD) with its 95% confidence interval(CI), and the target genes of significantly expression microRNAs were selected for enrichment analysis. Results Six studies published between 2017 and 2022 were finally included. The neurological outcomes were all assessed using the modified Rankin Scale (mRS). Meta-analysis showed miR-152-3p[MD=-0.31, 95%CI(-0.50, -0.13), adjusted P=0.006], miR-221-3p [MD= -0.26, 95%CI( -0.40, -0.11), adjusted P =0.005], and miR-34a- 5p[MD=-0.28, 95%CI( -0.46, -0.11), adjusted P = 0.009] were lower expressed in the cerebrospinal fluid of neurological good recovery patients than that of poor recovery patients with statistically significant. MiR-210-3p[MD=0.23, 95%CI(0.10, 0.37), adjusted P = 0.006] and miR-193b-3p[MD=0.16, 95%CI(0.12, 0.20), adjusted P = 0.002] were higher expressed in cerebrospinal fluid or serum of neurological good recovery patients than that of poor recovery patients with statistically significant. The enrichment analysis revealed that the PI3K-AKT signaling pathway was associated with neurological outcome after SAH. Conclusion There were differences in microRNA expression between different neurological functional recovery outcomes in SAH patients and microRNA was expected to be a biomarker to determine the neurological recovery outcome. The enrichment analysis validated the key role of the PI3K-AKT signaling pathway in the neurological recovery of SAH patients.

参考文献/References:

[1] SHANG Feng, ZHAO Hao, CHENG Weitao, et al. Predictive value of the serum albumin level on admission in patients with spontaneous subarachnoid hemorrhage[J]. Frontiers in Surgery, 2021, 8: 719226.
[2] CHEN Ruiqi, WEN Dingke, FU Wei, et al. Treatment effect of DNA framework nucleic acids on diffuse microvascular endothelial cell injury after subarachnoid hemorrhage[J]. Cell Proliferation, 2022, 55(4): e13206.
[3] GRIS T, LAPLANTE P, THEBAULT P, et al. Innate immunity activation in the early brain injury period following subarachnoid hemorrhage[J]. Journal of Neuroinflammation, 2019, 16(1): 253.
[4] LINDGREN A, VERGOUWEN M D, VAN DER SCHAAF I, et al. Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage[J]. The Cochrane Database of Systematic Reviews, 2018, 8(8): CD003085.
[5] 李长青, 柴尔青, 姜蕾.蛛网膜下腔出血预后相关生物标志物研究进展[J].医学综述, 2018, 24(10):2016-2021, 2026. LI Changqing, CHAI Erqing, JIANG Lei. Research progress of biomarkers associated with prognosis of subarachnoid hemorrhage[J]. Medical Recapitulate, 2018, 24(10): 2016-2021, 2026.
[6] 樊春荔, 何燕娟.缺血性脑卒中和短暂性脑缺血发作患者血清miR-23b-3p 水平变化的比较研究[J]. 现代检验医学杂志, 2020, 35(5): 51-54, 123. FAN Chunli, HE Yanjuan. Altered levels of serum miR-23b-3p in patients with ischemic stroke and transient ischemic attack[J]. Journal of Modern Laboratory Medicine, 2020, 35(5): 51-54, 123.
[7] 周红, 娜日罕, 荣钰, 等.扩张型心肌病患者两种治疗方法前后microRNA-126 和microRNA-30a 水平表达的研究[J]. 现代检验医学杂志, 2020, 35(4): 6-9. ZHOU Hong, NA Rihan, RONG Yu, et al. Study on the expression of microRNA-126 and microRNA-30a in patients with dilated cardiomyopathy before and after two treatments[J]. Journal of Modern Laboratory Medicine, 2020, 35(4): 6-9.
[8] 程永红, 肖小平.中重度颅脑损伤并发脑梗死患者血清miRNA-124 与miRNA-210 表达的临床意义[J].现代检验医学杂志, 2018, 33(3): 83-87. CHENG Yonghong, XIAO Xiaoping. Clinical application in detecting serum microRNA-124 and microRNA-210 in the moderately severe craniocerebral injury complicated with the traumatic cerebral infarction[J]. Journal of Modern Laboratory Medicine, 2018, 33(3): 83-87.
[9] ZHENG Lina, ZHANG Xin, LIU Liping, et al. Altered expression of specific microRNAs in plasma of aneurysmal subarachnoid hemorrhage patients[J]. Frontiers in Neurology, 2022, 13: 842888.
[10] 侯越, 赵妍, 王友明, 等.脑卒中患者血清胱抑素C水平与卒中后认知障碍相关性的Meta 分析[J]. 现代检验医学杂志, 2022, 37(2): 142-147. HOU Yue, ZHAO Yan, WANG Youming, et al. Meta analysis of the correlation between cystatin C level in stroke patientis and post stroke cognitive impairment[J]. Journal of Modern Laboratory Medicine, 2022, 37(2):142-147.
[11] 侯芳霞, 刘琳, 张维, 等.基于GEO 数据库筛选稳定性心绞痛患者外周血关键差异基因及诊断模型构建[J].现代检验医学杂志, 2022, 37(6): 19-23, 69. HOU Fangxia, LIU Lin, ZHANG Wei, et al. Identification of hub genes and differential expression genes for peripheral blood samples of stable angina pectoris based on GEO databases[J]. Journal of Modern Laboratory Medicine, 2022, 37(6): 19-23, 69.
[12] LAI Niansheng, ZHANG Jiaqi, QIN Feiyun, et al. Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhage[J]. Bioscience Reports, 2017, 37(1):BSR20160480.
[13] BACHE S, RASMUSSEN R, ROSSING M, et al. MicroRNA changes in cerebrospinal fluid after subarachnoid hemorrhage[J]. Stroke, 2017, 48(9):2391-2398.
[14] BACHE S, RASMUSSEN R, WOLCOTT Z, et al. Elevated miR-9 in cerebrospinal fluid is associated with poor functional outcome after subarachnoid hemorrhage[J]. Translational Stroke Research, 2020, 11(6): 1243-1252.
[15] 陈明, 张清秀, 魏秀娥.动脉瘤性蛛网膜下腔出血患者外周血miR?210 与TLR4 表达的相关性及临床意义[J]. 分子诊断与治疗杂志, 2020, 12(12): 1665-1669. CHEN Ming, ZHANG Qingxiu, WEI Xiue. Correlation of miR-210 and TLR4 expression in peripheral blood of patients with aneurysmal subarachnoid hemorrhage and its clinical significance[J]. Journal of Molecular Diagnosis and Therapy, 2020, 12(12): 1665-1669.
[16] 赵春艳, 屠淑敏, 薛冰, 等. 动脉瘤性蛛网膜下腔出血患者高压氧治疗后血清miR-193b-3p 水平及其意义题录[J].中华航海医学与高气压医学杂志, 2022,29(1): 102-107. ZHAO Chunyan, TU Shumin, XUE Bing, et al. The level and significance of miR-193b-3p in patients with aneurysmal subarachnoid hemorrhage after hyperbaric oxygen treatment[J]. Chinese Journal of Nautical Medicine and Hyperbaric Medicine, 2022, 29(1): 102-107.
[17] 陈飞虎, 陈建龙, 林海峰.动脉瘤性蛛网膜下腔出血患者介入治疗后miR?27a 表达水平及意义[J]. 海军医学杂志, 2022, 43(1): 105-108. CHEN Feihu, CHEN Jianlong, LIN Haifeng. Expression level and significance of miR-27a in patients with aneurysmal subarachnoid hemorrhage after interventional treatment[J]. Journal of Navy Medicine, 2022, 43(1): 105-108.
[18] 李凌, 王成, 王静, 等.2 型糖尿病微血管并发症患者血清miR-152,β2-GPI/ox-LDL 和β2-GP Ⅰ -Lp(a) 水平联合检测的价值研究[J]. 现代检验医学杂志, 2021, 36(2): 61-65. LI Ling, WANG Cheng, WANG Jing, et al. Clinical value of combined retention of serum miR-152,β2-GPI/ox-LDL and β2-GPI-Lp(a)in the type 2 diabetes patients with microvascular complications[J]. Journal of Modern Laboratory Medicine, 2021, 36(2): 61-65.
[19] LI Yunping, WU An, DAI Weimin, et al. Cerebrospinal fluid exosomal miR-152-3p predicts the occurrence of subarachnoid haemorrhage and regulates vascular smooth muscle cell dysfunction[J]. Folia Neuropathologica, 2022, 60(2): 185-194.
[20] XU Li, WU Jiang, LIU Yuan, et al. Peroxisome proliferator-activated receptor β/δ regulates cerebral vasospasm after subarachnoid hemorrhage via modulating vascular smooth muscle cells phenotypic conversion[J]. Molecular Medicine Reports, 2021, 24(6): 860.
[21] ZHAO Zhongyan, WU Chanji, HE Xiangying, et al. MiR-152-3p aggravates vascular endothelial cell dysfunction by targeting DEAD-box helicase 6 (DDX6) under hypoxia[J]. Bioengineered, 2021, 12(1): 4899-4910.
[22] 万淑君, 王成, 王静, 等.2 型糖尿病微血管并发症患者血清miR-16,miR-126 和miR-221 水平检测及临床意义[J]. 现代检验医学杂志, 2016, 31(5): 9-13. WAN Shujun, WANG Cheng, WANG Jing, et al. Study on serum levels of miR-16,miR-126 and miR-221 and their clinical significance in type 2 diabetes patients with or without microvascular complications[J]. Journal of Modern Laboratory Medicine, 2016, 31(5): 9-13.
[23] BAZAN H A, HATFIELD S A, O'MALLEY C B, et al. Acute loss of miR-221 and miR-222 in the atherosclerotic plaque shoulder accompanies plaque rupture[J]. Stroke, 2015, 46(11): 3285-3287.
[24] LIANG Huaibin, HE Jirong, TU Xuanqiang, et al. MicroRNA-140-5p: A novel circulating biomarker for early warning of late-onset post-stroke depression[J]. Journal of Psychiatric Research, 2019, 115: 129-141.
[25] 杨洋, 田蕊萍, 张利侠, 等.血清白介素-2 水平表达与卒中后抑郁相关性的Meta 分析[J]. 现代检验医学杂志, 2021, 36(2): 79-84, 117. YANG Yang, TIAN Ruiping, ZHANG Lixia, et al. Meta analysis of the correlation between serum interleukin-2 expression and post-stroke depression[J]. Journal of Modern Laboratory Medicine, 2021, 36(2): 79-84, 117.
[26] SUPRIYA M, CHRISTOPHER R, INDIRA DEVI B, et al. Circulating microRNAs as potential molecular biomarkers for intracranial aneurysmal rupture[J]. Molecular Diagnosis & Therapy, 2020, 24(3): 351-364.
[27] YANG Zhoujing, HU Sheng, HE Yinbin, et al. LINC00665 rescues bupivacaine induced neurotoxicity in human neural cell of SH-SY5Y through has-miR-34a-5p[J]. Brain Research Bulletin, 2021, 177: 210-216.
[28] CUI Ming, XIAO Huiwen, LI Yuan, et al. Total abdominal irradiation exposure impairs cognitive function involving miR-34a-5p/BDNF axis[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(9): 2333-2341.
[29] XU Yuelong, CHEN Ping, WANG Xianjun, et al. MiR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors[J]. Neuroscience Letters, 2018, 670: 94-104.
[30] TAI Yusi, PU Mei, YUAN Luyang, et al. MiR-34a-5p regulates PINK1-mediated mitophagy via multiple modes[J]. Life Sciences, 2021, 276: 119415.
[31] 王国玲, 张博刚, 郭娟, 等. 脑梗死患者血清miR-181d 和miR-210 水平表达与颈动脉狭窄程度及预后的相关性研究[J]. 现代检验医学杂志, 2021,36(6):64-69. WANG Guoling, ZHANG Bogang, GUO Juan, et al. Correlation between serum miR-181d and miR-210 levels in patients with cerebral infarction and the degree of carotid artery stenosis and prognosis[J]. Journal of Modern Laboratory Medicine, 2021, 36(6): 64-69.
[32] LI Fang, ZHANG Jie, LIAO Rui, et al. Mesenchymal stem cell-derived extracellular vesicles prevent neural stem cell hypoxia injury via promoting miR-210-3p expression[J]. Molecular Medicine Reports, 2020, 22(5): 3813-3821.
[33] LAI Niansheng, WU Degang, LIANG Tianyu, et al. Systemic exosomal miR-193b-3p delivery attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage in mice[J]. Journal of Neuroinflammation, 2020, 17(1): 74.
[34] CHEN Zhihao, YANG Junqing, ZHONG Jianjun, et al. MicroRNA-193b-3p alleviates focal cerebral ischemia and reperfusion-induced injury in rats by inhibiting 5-lipoxygenase expression[J]. Experimental Neurology, 2020, 327: 113223.
[35] YANG Tianye, WU Jiajun, GE Kui, et al. MicroRNA-193b-3p reduces oxidative stress and mitochondrial damage in rats with cerebral ischemia-reperfusion injury via the seven in absentia homolog 1/Jun N-terminal kinase pathway[J]. Bioengineered, 2022, 13(3): 6942-6954.
[36] ZHU Qiquan, ENKHJARGAL B, HUANG Lei, et al. AGGF1 attenuates neuroinflammation and BBB disruption via PI3K/Akt/NF-κB pathway after subarachnoid hemorrhage in rats[J]. Journal of Neuroinflammation, 2018, 15(1): 178.
[37] PENG Jianhua, PANG Jinwei, HUANG Lei, et al. LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1/PI3K/Akt pathway after subarachnoid hemorrhage in rats[J]. Redox Biology, 2019, 21: 101121.
[38] WANG Yue, PAN Xiaofei, LIU Guodong, et al. FGF-2 suppresses neuronal autophagy by regulating the PI3K/Akt pathway in subarachnoid hemorrhage[J]. Brain Research Bulletin, 2021, 173: 132-140.
[39] DIENEL A, VEETTIL R A, MATSUMURA K, et al. Agonism of the α7-acetylcholine receptor/PI3K/Akt pathway promotes neuronal survival after subarachnoid hemorrhage in mice[J]. Experimental Neurology, 2021, 344: 113792.
[40] WANG Pinyan, XUE Yanan, ZUO Yuchun, et al. Exosome-encapsulated microRNA-140-5p alleviates neuronal injury following subarachnoid hemorrhage by regulating IGFBP5-mediated PI3K/AKT signaling pathway[J]. Molecular Neurobiology, 2022, 59(12):7212-7228.

相似文献/References:

[1]樊春荔,何燕娟.缺血性脑卒中和短暂性脑缺血发作患者血清miR-23b-3p 水平变化的比较研究[J].现代检验医学杂志,2020,35(05):51.[doi:10.3969/j.issn.1671-7414.2020.05.013]
 FAN Chun-li,HE Yan-juan.Altered Levels of Serum miR-23b-3p in Patients with Ischemic Stroke and Transient Ischemic Attack[J].Journal of Modern Laboratory Medicine,2020,35(04):51.[doi:10.3969/j.issn.1671-7414.2020.05.013]
[2]邰国梅,郭 京,王高仁.胸部放疗患者血浆外泌体中miR-7-5p与miR-17-5p的表达及临床意义[J].现代检验医学杂志,2021,36(04):35.[doi:10.3969/j.issn.1671-7414.2021.04.008]
 TAI Guo-mei,GUO Jing,WANG Gao-ren.Expression and Clinical Significance of miR-7-5p and miR-17-5p in PlasmaExosomes of Patients with Thoracic Radiotherapy[J].Journal of Modern Laboratory Medicine,2021,36(04):35.[doi:10.3969/j.issn.1671-7414.2021.04.008]
[3]赵东肖,宋良月.蛛网膜下腔出血术后并发脑膜炎患者脑脊液CXCL13,IP-10水平表达及临床意义[J].现代检验医学杂志,2021,36(06):101.[doi:10.3969/j.issn.1671-7414.2021.06.021]
 ZHAO Dong-xiao,SONG liang-yue.Expression and Clinical Significance of CXCL13 and IP-10 Levels in Cerebrospinal Fluid of Patients with Meningitis after Subarachnoid Hemorrhage[J].Journal of Modern Laboratory Medicine,2021,36(04):101.[doi:10.3969/j.issn.1671-7414.2021.06.021]
[4]沈伟兴a,汤佳瑾b,傅 鹏a.2型糖尿病肾病患者外周血 microRNA-155水平与肾小球滤过率的相关性研究[J].现代检验医学杂志,2022,37(01):12.[doi:10.3969/j.issn.1671-7414.2022.01.003]
 SHEN Wei-xinga,TANG Jia-jinb,FU Penga.Correlation between microRNA-155 Level in Peripheral Blood and Glomerular Filtration Rate in Patients with Type 2 DiabeticNephropathy[J].Journal of Modern Laboratory Medicine,2022,37(04):12.[doi:10.3969/j.issn.1671-7414.2022.01.003]
[5]韩雪娇,刘红红,邢宁宁,等.支气管扩张伴支气管哮喘患者血清中microRNA-146水平表达与肺功能相关性分析[J].现代检验医学杂志,2022,37(02):100.[doi:10.3969/j.issn.1671-7414.2022.02.021]
 HAN Xue-jiao,LIU Hong-hong,XING Ning-ning,et al.Correlation Analysis between the Expression Level of micro RNA-146 in Serum and Lung Function in Patients with Bronchiectasis and Bronchial Asthma[J].Journal of Modern Laboratory Medicine,2022,37(04):100.[doi:10.3969/j.issn.1671-7414.2022.02.021]
[6]张玲玲,张小霞,於潇潇,等.非小细胞肺癌患者血浆miR-520f,miR-143-3p表达与病理特征和预后的相关性研究[J].现代检验医学杂志,2022,37(03):69.[doi:10.3969/j.issn.1671-7414.2022.03.014]
 ZHANG Ling-ling,ZHANG Xiao-xia,YU Xiao-xiao,et al.Correlation Study on Plasma miR-520f and miR-143-3p Expression with Pathological Features and Prognosis in Patients with Non-small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2022,37(04):69.[doi:10.3969/j.issn.1671-7414.2022.03.014]
[7]黄 英,陈 兰,周英艳,等.急性主动脉夹层患者血浆miR-30a及D-二聚体水平检测对临床预后判断价值[J].现代检验医学杂志,2022,37(03):187.[doi:10.3969/j.issn.1671-7414.2022.03.039]
 HUANG Ying,CHEN Lan,ZHOU Ying-yan,et al.Clinical Prognostic Value of Plasma miR-30a and D-dimer Levels in Patients with Acute Aortic Dissection[J].Journal of Modern Laboratory Medicine,2022,37(04):187.[doi:10.3969/j.issn.1671-7414.2022.03.039]
[8]王 路,叶 莎,韩 霞,等.循环外泌体miRNA 检测对肝细胞癌临床诊断效能的Meta 分析[J].现代检验医学杂志,2022,37(04):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
 WANG Lu,YE Sha,HAN Xia,et al.Meta-Analysis of the Diagnostic Value of Circulating Exosomes miRNA Detection for Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2022,37(04):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
[9]沈开元a,曲晓力a,代小丽b,等.卵巢功能减退患者卵泡液外泌体差异表达miRNA 筛选及生物学功能分析[J].现代检验医学杂志,2023,38(05):17.[doi:10.3969/j.issn.1671-7414.2023.05.004]
 SHEN Kaiyuana,QU Xiaolia,DAI Xiaolib,et al.Screening and Biological Function Analysis of Follicular Fluid-derived Exosomes Differentially Expressed miRNA in Patients with Diminished Ovarian Reserve[J].Journal of Modern Laboratory Medicine,2023,38(04):17.[doi:10.3969/j.issn.1671-7414.2023.05.004]
[10]王巧祎,王宁宁,刘晴晴,等.EB 病毒BART miRNAs 在胃癌中的作用机制研究进展[J].现代检验医学杂志,2023,38(05):199.[doi:10.3969/j.issn.1671-7414.2023.05.038]
 WANG Qiaoyi,WANG Ningning,LIU Qingqing,et al.Research Progress on the Mechanism of Epstein-Barr Virus BART miRNAs in Gastric Cancer[J].Journal of Modern Laboratory Medicine,2023,38(04):199.[doi:10.3969/j.issn.1671-7414.2023.05.038]

备注/Memo

备注/Memo:
作者简介:韩岳(1984-),男,本科,副主任医师,研究方向:神经外科学相关疾病,E-mail:hanyue8011@sohu.com。
更新日期/Last Update: 2023-07-15